This purchase order award to Ecolab Inc.'s Life Sciences division, valued at $543,325, represents an administrative de-obligation of unexpended and expiring Fiscal Year 2021 funding by the National Institutes of Health Clinical Center. The contract, issued on August 1, 2018, with an ultimate completion date of January 31, 2024, addresses the de-obligation requirements under 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability for these fiscal year funds. As a firm fixed-price purchase order with no set-aside designation, this award reflects the competitive positioning of Ecolab's specialized bio-decontamination capabilities within the federal marketplace.
Ecolab Inc., headquartered in St. Paul, Minnesota, through its Life Sciences Ecolab division based in Horsham, Pennsylvania, is a global leader in contamination control and infection prevention solutions. The company's federal portfolio demonstrates substantial expertise in supplying hydrogen peroxide vapor decontamination systems, particularly through its Bioquell brand technology, along with associated maintenance services, calibration support, and operator training. This award to the NIH Clinical Center reflects Ecolab's established role as a trusted provider of critical decontamination infrastructure to multiple federal health and scientific agencies, including the Department of Veterans Affairs, Food and Drug Administration, Centers for Disease Control and Prevention, and Department of the Army Medical Command.
Generated 4/25/26, 9:45 AM